SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

The MELANIA crypto token continues to face intense community backlash and skepticism, with investors frequently labeling it a "pump-and-dump" scam that has experienced a near-total loss of value since its launch. Discussion forums are dominated by users venting frustration over significant financial losses, questioning the legitimacy of the project's developers, and drawing parallels between this asset and other controversial Trump-family-backed ventures.

Duos Technologies Group, Inc. designs, develops, deploys, and operates intelligent technology solutions supporting rail, logistics, intermodal and government customers that streamlines operations, improves safety and reduces costs. It offers imaging, safety and security, software, and services. The firm also provides cutting edge solutions that automate the mechanical and security inspection of fast moving trains, trucks and automobiles through a broad range of proprietary hardware, software, information technology and artificial intelligence. The company was founded on May 31, 1994 and is headquartered in Jacksonville, FL.

Duos Technologies Group Inc

Duos Technologies is trending as investors digest the recent $65M public offering and the signing of a major GPU-as-a-Service contract with Hydra Host. The community is actively debating the potential for an M&A or joint venture with TSSI to scale edge AI infrastructure, alongside bullish sentiment surrounding the company's modular data center strategy and new leadership's ability to drive rapid deal flow.

Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTLido, Elyxyb, and Gloperba. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.

Scilex Holding Company

Scilex Holding Company is currently under intense scrutiny following a federal lawsuit against BNY Mellon and others, alleging a scheme that misappropriated DVLT shares as collateral to trigger forced liquidations. Investors are actively debating the potential for a massive supply shock if the court orders a share freeze, while simultaneously voicing significant frustration over the lack of transparency regarding financial reporting and the company's complex, interlinked strategic investments.

The Bank of Nova Scotia engages in the provision of financial products and services including personal, commercial, corporate, and investment banking. It operates through the following segments: Canadian Banking, International Banking, Global Wealth Management, Global Banking and Markets, and Other. The company was founded on March 30, 1832 and is headquartered in Toronto, Canada.

Bank Of Nova Scotia

Bank of Nova Scotia is experiencing significant investor activity driven by its recent strategic equity investment in KeyCorp and a focus on expanding its North American footprint. Market participants are actively discussing the bank's valuation, potential growth catalysts, and dividend sustainability amid shifting interest rate expectations.

Air Canada engages in the provision of airline transportation services. Its services cover full-service airline, scheduled passenger and cargo services, serving more than two hundred airports on six continents. It operates through the following geographical segments: Canada, U.S. Transborder, Atlantic, Pacific, and Other. The company was founded on April 11, 1936 and is headquartered in Saint-Laurent, Canada.

Air Canada Inc. - Ordinary Shares (Voting and Variable Voting)

Air Canada Inc.

Air Canada is seeing increased investor scrutiny as the market evaluates the airline's latest share buyback program and its ability to improve financial performance amid fluctuating fuel costs and competitive industry conditions. Community sentiment remains polarized, with some traders optimistic about long-term potential following recent NCIB authorization, while others express frustration over extended periods of price stagnation and call for leadership changes.

PAW Chain has launched the world’s first Layer 3-centric blockchain, enhancing scalability and inter-chain operability across networks. The roadmap features a decentralized exchange, merchant services, and a DAO, all optimized for high-volume, low-cost transactions. Leveraging smart contracts and EVM compatibility, PAW Chain is set to transform digital finance by providing secure, efficient solutions, allowing any project to go multi-chain, underscored by a community-driven governance model and rigorous security standards including regular security audits

PAW is gaining traction as investors track the development of its custom L3 blockchain, which aims to unify liquidity across multiple networks. Community discussion is heavily focused on upcoming roadmap milestones, the potential of its cross-chain infrastructure, and the project's strategy to move beyond its origins into a professional, enterprise-ready ecosystem.

Axelar delivers secure interchain communication. That means dApp users can interact with any asset, any application, on any chain, with one click. You can think of it as Stripe for Web3. Developers interact with a simple API atop a permissionless network that routes messages and ensures network security via proof-of-stake consensus.  Axelar is a blockchain that connects blockchains. To do this securely, Axelar network uses proof-of-stake consensus. Network validators produce new blocks, participate in multiparty signing and vote on external chain states. Tokenholders stake the AXL token, delegating tokens to a validator’s staking pool and receiving rewards, minus the validator’s commission.  The AXL token is used for governance and to pay network transaction fees to validators and tokenholders. However, users of the Axelar network do not need to hold the token. Conversions into AXL tokens and destination-chain tokens are handled on the back end, so that users need only pay gas once, in the source-chain token.  Axelar network rewards are “inflationary” — they increase the total supply of AXL — but there is potential for supply to become deflationary based on the transaction fee mechanic described above.

Axelar

Axelar is drawing significant investor interest as the market closely monitors its role in cross-chain interoperability, specifically regarding its integration with major projects like the XRP Ledger and stablecoin infrastructure. Community sentiment remains polarized, with many users actively discussing the balance between long-term technological potential and short-term volatility following recent development updates and team transitions.

|The Artificial Superintelligence (ASI) Alliance is the world’s largest open-source initiative dedicated to decentralized Artificial General Intelligence (AGI). Formed in April 2024, the ASI Alliance unites SingularityNET, Fetch.ai, and Ocean Protocol, with CUDOS joining as a network member shortly after. The ASI Alliance was established through a community-approved tokenomic merger—combining $AGIX, $FET, and $OCEAN into a single token: $FET. This unified token underpins a collaborative framework designed to scale open-source AI and stand as the largest open-sourced, independent entity in AI research and development. The Alliance is committed to accelerating the advancement of decentralized Artificial General Intelligence (AGI) and, ultimately, Artificial Superintelligence (ASI). It provides a robust, open-source innovation stack, empowering developers, enterprises, and researchers globally to build ethical, scalable, and groundbreaking AI solutions. This ensures that advanced intelligence remains a shared, accessible resource, fostering innovation beyond centralized systems and promoting a future where AI benefits all.

Fetch.ai

Fetch.ai is garnering community attention due to perceived long-term value and strong price support, with investors actively discussing potential entry points within the broader artificial intelligence and decentralized technology sector.

Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Christopher Garcia and Roeland Nusse on August 12, 2015 and is headquartered in South San Francisco, CA.

Surrozen Inc

Surrozen is trending as investors anticipate key Phase 1 clinical data for its SZN-043 liver cirrhosis program and updates on its ophthalmology collaborations. The community is heavily focused on potential buyout prospects and the company's long-term value, with active discussions comparing its Wnt-modulating technology to recent successful acquisitions in the sector.

Mobilicom Ltd. is an end-to-end provider of cyber security and smart solutions for drones, robotics and autonomous platforms. It designs, develops and delivers solutions targeting global drone, robotics and autonomous system manufacturers. The firm holds patented technology and know-how for Mobile Mesh networking. Its customers include corporates, governments and military departments. The company was founded by Oren Elkayam and Yossi Segal in 2006 and is headquartered in Shoham, Israel.

Mobilicom Limited

Mobilicom is capturing market attention as global defense spending and the demand for cybersecure, autonomous drone solutions continue to accelerate. The community is actively tracking the stock's potential for growth tied to expanding U.S. and global defense contracts, while discussing the impact of recent institutional interest and the company's strategic integration of its technology into Tier-1 drone platforms.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Plus Therapeutics (PSTV) Reports Break-Even Earnings for Q4

Plus (PSTV) delivered earnings and revenue surprises of +100.00% and +2.02%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Immunovant Stock Surges 17% in 3 Months: What's Driving It?

IMVT gains 17% in three months as IMVT-1402 advances across autoimmune trials, with multiple data readouts due in 2026-2027, and $994.5M cash backing development.

AMRN Stock Soars 37.7% in a Year: Here's What You Need to Know 

Amarin shares surge 37.7% in a year as restructuring, cost cuts and expanding Vazkepa partnerships for international growth fuel optimism.

Is Assertio (ASRT) Outperforming Other Medical Stocks This Year?

Here is how Assertio (ASRT) and Aura Biosciences, Inc. (AURA) have performed compared to their sector so far this year.

Assertio (ASRT) Projected to Post Quarterly Earnings on Wednesday

Assertio (NASDAQ:ASRT) will be releasing its Q4 2025 earnings before the market opens on Wednesday, March 11. (View Earnings Report at...

Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026

Assertio Holdings, Inc. (Assertio) (Nasdaq: ASRT) today announced that it will release fourth quarter and full year 2025 financial results on Monday, March 16, 2026, after the market close. Following...

REGN & SNY's Dupixent Gets CHMP Nod for Pediatric Use in Urticaria 

Regeneron and Sanofi win CHMP backing to expand Dupixent use to young CSU patients, with EU and U.S. decisions poised to unlock a new growth avenue.

PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View

Puma Biotechnology Q4 earnings top estimates with 28% revenue jump, but weak 2026 outlook sparks 14% after-hours plunge.

PRGO Q4 Earnings Miss, Sales Beat, Stock Down on Weak 2026 View

Perrigo misses Q4 EPS estimates. Its 2026 sales and profit estimates are below expectations as Infant Formula headwinds persist. Shares slide on weak guidance.


Lipocine (LPCN) Soars 5.5%: Is Further Upside Left in the Stock?

Lipocine (LPCN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

ASRT
Assertio Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ASRT News

ASRTAssertio Holdings Inc